Capreomycin is an antibiotic, which is used in combination other antituberculosis drugs fro the treatment of pulmonary infections caused by capreomycin-susceptible strains of M. tuberculosis when the primary agents (isoniazid, rifampin, ethambutol, aminosalicylic acid, and streptomycin) have been ineffective or cannot be used because of toxicity or the presence of resistant tubercle bacilli. Little is known about capreomycin's exact mechanism of action, but it is thought to inhibit protein synthesis by binding to the 70S ribosomal unit. Capreomycin also binds to components in the bacterial cell which result in the production of abnormal proteins.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2363965 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | CAPASTAT SULFATE Approved UseCapastat Sulfate, which is to be used concomitantly with other appropriate antituberculosis agents, is indicated in pulmonary infections caused by capreomycin-susceptible strains of M. tuberculosis when the primary agents (isoniazid, rifampin, ethambutol, aminosalicylic acid, and streptomycin) have been ineffective or cannot be used because of toxicity or the presence of resistant tubercle bacilli. Susceptibility studies should be performed to determine the presence of a capreomycin-susceptible strain of M. tuberculosis. Launch Date1971 |
Sample Use Guides
Intravenously: Capastat Sulfate (Capreomycin for Injection) should be diluted in
100 mL of 0.9% Sodium Chloride Injection and administered over 60 minutes.
Intramuscularly — Reconstituted Capastat Sulfate should be given by deep intramuscular injection into a large muscle mass, since superficial injection may be associated with increased pain and the development of sterile abscesses. For administration of a 1-g dose, the entire contents of the vial should be given. For doses lower than 1 g, the following dilution table may be used.
Route of Administration:
Other
| Substance Class |
Mixture
Created
by
admin
on
Edited
Fri Dec 15 15:41:09 GMT 2023
by
admin
on
Fri Dec 15 15:41:09 GMT 2023
|
| Record UNII |
9H8D3J7V21
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C2363
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
||
|
NCI_THESAURUS |
C280
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2221250
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
1405-36-3
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
ALTERNATIVE | |||
|
C73797
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
1091006
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
1987
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | RxNorm | ||
|
DBSALT000443
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
9H8D3J7V21
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
215-776-8
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
1405-37-4
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
m3029
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID30930861
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
SUB01029MIG
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
755904
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | |||
|
CAPREOMYCIN SULFATE
Created by
admin on Fri Dec 15 15:41:09 GMT 2023 , Edited by admin on Fri Dec 15 15:41:09 GMT 2023
|
PRIMARY | Description: A white or almost white powder. Solubility: Very soluble in water, practically insoluble in ethanol (~750 g/l) TS and in ether. Category: Antituberculosis drug. Storage: Capreomycin sulfate should be kept in a tightly closed container or, if sterile, in a hermetically closed container. Labelling: The label states, where applicable:(1) that the substance is free from bacterial endotoxins,(2) that the substance is sterile. Definition: Capreomycin sulfate is a mixture of the sulfates of antimicrobial polypeptides produced by the growth of Streptomyces capreolus. It contains not less than 70.0% of capreomycin, calculated with reference to the dried substance and taking into account the sum of capreomycin IA, IB, IIA and IIB. The contents of capreomycin IA and IB is not less than 90.0% of the sum of capreomycin IA, IB, IIA and IIB. |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
It has a potency equivalent to NLT 700 ?g/mg and NMT 1050 ?g/mg of capreomycin;
capreomycin 1 - NLT 90.0%
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |